The Nasopharyngeal Carcinoma (NPC) Research Day 2025, organised by the Nasopharyngeal Carcinoma Society of Malaysia in collaboration with UCSI University, served as a valuable platform for students and researchers to exchange knowledge, explore new ideas, and contribute to the growing body of NPC research. The competition featured over 60 participating teams, bringing together researchers and students to showcase their contributions to the field of nasopharyngeal carcinoma.

Guided by Dr Shamala Salvamani and Dr Anil Philip Kunnath, IMU Biomedical Science students Dharsan Shunmugam, Milind Kuruvath Santhosh, and Willem Tan proudly represented IMU at the 13th Nasopharyngeal Carcinoma Research Day 2025 on 27 February at UCSI University, where they clinched First Place for Best Poster Presentation.

Their research focused on the role of FOXQ1 in NPC progression, particularly its influence on epithelial-mesenchymal transition (EMT), angiogenesis, and key biomarkers such as VEGFA, EGFR, and E-cadherin. By analysing the molecular pathways involving FOXQ1, their study provided insights into its potential as a biomarker and its relevance in NPC metastasis.

Milind Kuruvath Santhosh noted that engaging with experts in the field provided new perspectives on their work. “Discussing our findings with researchers who have years of experience in NPC research was incredibly insightful. It made me realise how much depth there is to this field and how much more there is to explore,” he added.

For Willem Tan, the competition was an opportunity to develop confidence in presenting scientific research. “Standing in front of experts and peers to defend our findings was initially daunting, but it turned out to be a great experience. The feedback we received helped us refine our understanding and approach to research communication,” he shared.

Dr Shamala Salvamani emphasised that this recognition highlights the students’ dedication to advancing research in cancer biology. She noted that studies focusing on molecular mechanisms, such as FOXQ1’s role in NPC, are crucial in expanding scientific understanding and potentially guiding future therapeutic strategies.

Dr Anil Philip Kunnath added, “Participating in this event provided a platform not only to present our research but also to engage in meaningful discussions with experts and fellow researchers. Events like these foster collaboration, encourage new perspectives, and contribute to scientific progress in the field of cancer research.”

The IMU team expressed their gratitude for the opportunity to present their work and engage in discussions at the Nasopharyngeal Carcinoma (NPC) Research Day 2025, which will continue to shape their academic and research journey.

Written by Dharsan A/L Shunmugam (BM1/23 student)